Vemurafenib effectively controlled Chemotherapy-refractory Intrahepatic Cholangiocarcinoma with BRAF V600E Mutation: a case report and literature review.

Weng, Shanshan; Zhang, Ding; Yang, Mengyuan; Wang, Liuhong; Yuan, Ying

Weng, Shanshan; Zhang, Ding; Yang, Mengyuan; Wang, Liuhong; Yuan, Ying.

Afiliación

Weng S; Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, China.
Zhang D; Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, China.
Yang M; Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, China.
Wang L; Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, China.
Yuan Y; Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, China.

Z Gastroenterol ; 60(12): 1787-1791, 2022 Dec.

Article en En | MEDLINE | ID: mdl-35584781

Asunto(s)

Proteínas Proto-Oncogénicas B-raf; Humanos; Vemurafenib/uso terapéutico; Mutación/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas B-raf Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Z Gastroenterol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google